Renal Cancer - Results from #5660

Design and Reporting of Targeted Anti-Cancer Preclinical Studies: A Meta-Analysis of Animal Studies Investigating Sorafenib Antitumor Efficacy June 7, 2016

DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas June 7, 2016

Biomarkers for Wilms Tumor: a Systematic Review June 7, 2016

Novel imaging in renal cell carcinoma June 6, 2016

Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Versus Malignant Disease and Low- Versus High-Risk Renal Tumors June 6, 2016

Update on active surveillance for clinical T1 renal tumors June 5, 2016

Lymph node dissection for renal cell carcinoma: what are we missing? June 5, 2016

Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population June 1, 2016

Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma May 31, 2016

Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study May 31, 2016

Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan May 31, 2016

Papillary Renal-Cell Carcinoma May 30, 2016

Anti-Tumor Effect via Passive Anti-angiogenesis of PEGylated Liposomes Encapsulating Doxorubicin in Drug Resistant Tumors May 30, 2016

Racial disparities in renal cell carcinoma: a single-payer healthcare experience May 29, 2016

The Value of Contrast-Enhanced Ultrasonography and Contrast-Enhanced CT in the Diagnosis of Malignant Renal Cystic Lesions: A Meta-Analysis May 27, 2016

Survival in Patients with Primary Metastatic Renal Cell Carcinoma Treated with Sunitinib with or Without Previous Cytoreductive Nephrectomy: Results From a Population-Based Registry May 26, 2016

Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours May 26, 2016

Risk Factors for De Novo Malignancies in Women After Kidney Transplantation: A Multicenter Transversal Study May 25, 2016

A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies May 25, 2016

Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy May 25, 2016

Page 284 of 456